Latest Breaking News On - Octopus ventures - Page 7 : comparemela.com

Integrated cancer biotech Infinitopes secures £12 8m seed financing to enhance its Precision Immunomics antigen discovery technologies to target five more cancers

Integrated cancer biotech Infinitopes secures £12 8m seed financing to enhance its Precision Immunomics antigen discovery technologies to target five more cancers
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofPaul klenermanJonathan kwokHugo villanuevaMark middletonJohnw cassidyNicola ternettePhil mastersonJulia schrameierOxford universityCancer research horizonsUniversity of oxfordCancer research instituteCancer research horizonOxford university bioescalator innovation building

Integrated cancer biotech Infinitopes secures £12 8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1

United kingdomCity ofNicola ternetteHugo villanuevaMark middletonPaul klenermanJohnw cassidyPhil mastersonJonathan kwokJulia schrameierCancer research horizonCancer foundationCancer research united kingdomRegulatory agencyCancer research instituteUnited kingdom future economy investor partnership

Infinitopes Raises £12 8M in Seed Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Jonathan kwokCancer foundationCancer research instituteCancer research horizonsInfinitopes precision immunomicsUnited kingdom basedOctopus venturesKindred capitalManta rayMartlet capitalMeltwind advisorySaras capitalWilbe capital

Integrated cancer biotech Infinitopes secures £12 8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

/PRNewswire/ Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine.

United kingdomCity ofPhil mastersonJulia schrameierPaul klenermanMark middletonHugo villanuevaJonathan kwokNicola ternetteJohnw cassidyUnited kingdom future economy investor partnershipRegulatory agencyCancer research horizonCancer research horizonsCancer foundationCancer research institute

Integrated cancer biotech Infinitopes secures £12 8m seed financing to enhance its Precision ImmunomicsTM antigen discovery technologies to target fiv

Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1Oxford, UK (April 30th, 2024) – Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune.

United kingdomCity ofJonathan kwokPaul klenermanNicola ternetteJulia schrameierMark middletonJohnw cassidyPhil mastersonHugo villanuevaCancer research united kingdomCancer foundationCancer research instituteRegulatory agencyOxford universityUnited kingdom future economy investor partnership